Protein Corona Composition of Gold Nanocatalysts
March 14, 2024
Source
ACS Pharmacology & Translational Science
Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials
December 13, 2023
Source
Journal of Nanobiotechnology
A Mechanism Underpinning the Bioenergetic Metabolism-Regulating Function of Gold Nanocatalysts
September 28, 2023
Source
Small
Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension
June 8, 2023
Source
eClinicalMedicine
Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression
January 11, 2021
Source
BMJ Journals
Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis
February 11, 2020
Source
Scientific Reports